安裝中文字典英文字典辭典工具!
安裝中文字典英文字典辭典工具!
|
- Interim Policy Statement: Prescribing Wegovy® and Mounjaro® for Weight . . .
This interim policy statement outlines South East London’s (SEL) criteria for access to National Institute of Health and Care Excellence (NICE) approved weight management medications semaglutide (brand name: Wegovy®) and tirzepatide (brand name: Mounjaro)® on the NHS
- Enhanced Service Specification – Weight Management 2025 26 - NHS England
Enhanced Service Specification – Weight Management 2025 26 © NHS England 2025 8 A reference guide has been developed for primary care networks, healthcare practices and pharmacies interested in training staff, and individuals interested in undertaking training, to become a healthy weight coach
- GPs to prescribe Mounjaro from late June to prioritised patient . . .
GPs will be able to prescribe Mounjaro weight-loss injections from late June to ‘prioritised patient cohorts’ set out by NHS England in new guidance NHS England’s ‘interim commissioning guidance’ has stipulated that ICBs must meet the costs of funding access to tirzepatide (Mounjaro) for obesity in primary care settings from 23 June this year
- Weight Management - Tirzapetide (Mounjaro) - DRAFT (Remedy BNSSG ICB)
Overview ***Update 13 6 25*** NICE guidelines (1) in December 2024 advised that Tirzapetide (Mounjaro) should be available in primary care for weight management and NHS England have been working towards implementation (provisionally for 23rd June 2025) The BNSSG Weight Management Group (including representatives from BNSSG ICB, GPCB and Avon LMC) have been developing a LES so that this can
- Focus on: Tirzepatide (Mounjaro) for weight management in General Practice
GPs should engage in prescribing where clinically appropriate and safely resourced to do so GPC England has produced a Focus on Tirzepatide (Mounjaro) for weight management in General Practice document, which explains how Tirzepatide is used, commissioning arrangements (responsibility for funding lies with ICBs), and responding to information
- Greenwich Clinical Matters - selondonics. org
SEL has published an interim policy statement on prescribing Wegovy® and Mounjaro® for weight management GPs can refer eligible people who meet the criteria above to specialist weight management services to access weight management medicines
- GPs to Begin Prescribing Mounjaro for Prioritised Patient Cohorts from . . .
NHS England has announced that general practitioners will commence prescribing Mounjaro (tirzepatide) for weight management from 23 June 2025 This initiative targets prioritised patient cohorts, aligning with a phased rollout strategy designed to manage primary care capacity effectively
- Tirzepatide (Mounjaro) Prescribing- A Message from the ICB
This Technology Appraisal makes Tirzepatide available for weight management, under the brand name Mounjaro Unlike previous weight management medication, this can be prescribed in Primary Care, however it still needs the same wrap around services as Wegovy (semaglutide), so that patients are supported to make the changes needed for the
|
|
|